CVS (CVS) disappointed Wall Street Wednesday by missing revenue estimates and revising down its 2024 guidance and expects to raise insurance plan prices in the coming year as it adjusts for Medicare ...

Diversified healthcare company CVS Health (NYSE:CVS) reported in Q3 CY2025, with sales up 7.8% year on year to $102.9 billion. Its non-GAAP profit of $1.60 per share was 17.9% above analysts’ ...

Again, these numbers demonstrate why the market has been bullishly supporting CVS' ongoing recovery by +57.4% from the December 2024 bottoms, with the 22 adj EPS upward revisions over the past three ...